JP2015143248A5 - - Google Patents

Download PDF

Info

Publication number
JP2015143248A5
JP2015143248A5 JP2015057637A JP2015057637A JP2015143248A5 JP 2015143248 A5 JP2015143248 A5 JP 2015143248A5 JP 2015057637 A JP2015057637 A JP 2015057637A JP 2015057637 A JP2015057637 A JP 2015057637A JP 2015143248 A5 JP2015143248 A5 JP 2015143248A5
Authority
JP
Japan
Prior art keywords
unit dose
dha
pharmaceutical composition
composition
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015057637A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015143248A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015143248A publication Critical patent/JP2015143248A/ja
Publication of JP2015143248A5 publication Critical patent/JP2015143248A5/ja
Pending legal-status Critical Current

Links

JP2015057637A 2009-02-02 2015-03-20 認知機能改善および心拍数低下のための方法 Pending JP2015143248A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US14931009P 2009-02-02 2009-02-02
US61/149,310 2009-02-02
US18354809P 2009-06-02 2009-06-02
US61/183,548 2009-06-02

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011548414A Division JP2012516852A (ja) 2009-02-02 2010-02-02 認知機能改善および心拍数低下のための方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018073345A Division JP2018104477A (ja) 2009-02-02 2018-04-05 認知機能改善および心拍数低下のための方法

Publications (2)

Publication Number Publication Date
JP2015143248A JP2015143248A (ja) 2015-08-06
JP2015143248A5 true JP2015143248A5 (enExample) 2015-12-24

Family

ID=42041547

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2011548414A Withdrawn JP2012516852A (ja) 2009-02-02 2010-02-02 認知機能改善および心拍数低下のための方法
JP2015057637A Pending JP2015143248A (ja) 2009-02-02 2015-03-20 認知機能改善および心拍数低下のための方法
JP2018073345A Pending JP2018104477A (ja) 2009-02-02 2018-04-05 認知機能改善および心拍数低下のための方法
JP2019238726A Pending JP2020050675A (ja) 2009-02-02 2019-12-27 認知機能改善および心拍数低下のための方法
JP2022023007A Withdrawn JP2022059063A (ja) 2009-02-02 2022-02-17 認知機能改善および心拍数低下のための方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2011548414A Withdrawn JP2012516852A (ja) 2009-02-02 2010-02-02 認知機能改善および心拍数低下のための方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2018073345A Pending JP2018104477A (ja) 2009-02-02 2018-04-05 認知機能改善および心拍数低下のための方法
JP2019238726A Pending JP2020050675A (ja) 2009-02-02 2019-12-27 認知機能改善および心拍数低下のための方法
JP2022023007A Withdrawn JP2022059063A (ja) 2009-02-02 2022-02-17 認知機能改善および心拍数低下のための方法

Country Status (8)

Country Link
US (2) US20100203123A1 (enExample)
EP (2) EP2391361A1 (enExample)
JP (5) JP2012516852A (enExample)
CN (3) CN108324706A (enExample)
AU (2) AU2016201382A1 (enExample)
CA (1) CA2751275A1 (enExample)
HK (1) HK1202243A1 (enExample)
WO (1) WO2010088700A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8207363B2 (en) 2009-03-19 2012-06-26 Martek Biosciences Corporation Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
US20110177061A1 (en) * 2009-07-10 2011-07-21 Martek Biosciences Corporation Methods of treating and preventing neurological disorders using docosahexaenoic acid
WO2012159092A2 (en) * 2011-05-19 2012-11-22 The Regents Of The University Of California Medical food for cognitive decline
US20130084272A1 (en) * 2011-09-29 2013-04-04 Philippe Perrin Compositions, kits and methods for nutritional supplementation with twelve carbon chain fatty acids and twelve carbon chain acylglycerols
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
AU2014233421A1 (en) * 2013-03-15 2015-09-24 Genspera, Inc. Methods of making cancer compositions
EP3626806B1 (en) 2013-12-20 2024-06-19 Mara Renewables Corporation Methods of recovering oil from microorganisms
TR201503136A2 (tr) * 2015-03-16 2016-09-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dronedaron ve esansiyel yağ asitlerinin farmasötik kompozisyonları.
US10851395B2 (en) 2016-06-10 2020-12-01 MARA Renewables Corporation Method of making lipids with improved cold flow properties
WO2018116093A1 (en) 2016-12-22 2018-06-28 MARA Renewables Corporation Methods for producing biomass rich in dha, palmitic acid and protein using a eukaryotic microorganism
JP7101087B2 (ja) * 2018-09-05 2022-07-14 株式会社 伊藤園 軽度認知障害に対する緑茶成分の有効性評価方法
FR3092968B1 (fr) * 2019-02-22 2021-05-21 Microphyt Complement alimentaire
EP4009965A4 (en) * 2019-08-08 2023-11-15 Swinburne University of Technology Uses of long-chain polyunsaturated fatty acids
AU2021245403A1 (en) 2020-04-03 2022-11-24 MARA Renewables Corporation Microbial oils with high levels of omega-3 fatty acids
DE102020115238A1 (de) * 2020-06-09 2021-12-09 Pm-International Ag Nahrungsergänzungsmittel und Nahrungsmittel
WO2022006496A1 (en) * 2020-07-02 2022-01-06 Pear Therapeutics, Inc. Systems, methods, and devices for generating and administering digital therapeutic placebos and shams
CA3204546A1 (en) * 2021-01-15 2022-07-21 Cambridge Cognition Limited Methods and systems of identifying individuals for perioperative neurocognitive disorder and/or post-viral cognitive impairment
WO2024155781A1 (en) * 2023-01-18 2024-07-25 Bioventures, Llc Method of preventing and treating alzheimer's disease and related dementias with drugs inhibiting the interaction between 14-3-3g protein and hexokinase-1 protein
JP2025079778A (ja) * 2023-11-10 2025-05-22 ダイドーグループホールディングス株式会社 生理機能改善用の組成物
WO2025100476A1 (ja) * 2023-11-10 2025-05-15 国立大学法人京都大学 生理機能改善用の組成物

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
EP0707487B1 (en) * 1993-06-09 2004-04-14 Martek Biosciences Corporation Methods and pharmaceutical compositions useful for treating neurological disorders
US20050027004A1 (en) * 1993-06-09 2005-02-03 Martek Biosciences Corporation Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
EP0776356B1 (de) 1994-08-16 1999-06-30 Dr. Frische GmbH Verfahren zur gewinnung von nicht wasserlöslichen, nativen produkten aus nativen stoffgemengen mit hilfe der zentrifugalkraft
US6582941B1 (en) * 1995-04-17 2003-06-24 Japan As Represented By Director-General Of Agency Of Industrial Science And Technology Microorganisms capable of producing highly unsaturated fatty acids and process for producing highly unsaturated fatty acids by using the microorganisms
JP3985035B2 (ja) * 1995-09-14 2007-10-03 独立行政法人産業技術総合研究所 (n−6)系ドコサペンタエン酸含有油脂ならびに該油脂の製造方法および用途
DE60012934T2 (de) 1999-02-26 2005-08-25 Martek Biosciences Corp. Verfahren zum Abtrennen von einem Docosahexaensäure enthaltenden Triglycerid aus einem Triglyceridgemisch
WO2001051598A1 (en) 2000-01-11 2001-07-19 Monsanto Technology Llc Process for making an enriched mixture of polyunsaturated fatty acid esters
PT1252324E (pt) 2000-01-19 2010-12-16 Martek Biosciences Corp Processo de extracção sem solvente
DK1272049T3 (da) 2000-04-12 2010-03-22 Gea Westfalia Separator Gmbh Fremgangsmåde til fraktionering af olie- og polær lipidholdige oprindelige råmaterialer under brug af alkohol og centrifugering
WO2002092540A1 (en) 2001-05-14 2002-11-21 Martek Biosciences Corporation Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsatruated fatty acids from microbes, genetically modified plant seeds and marine organisms
US20070004678A1 (en) 2001-05-14 2007-01-04 Gerhard Kohn Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes
WO2003003981A2 (en) * 2001-07-05 2003-01-16 Vital Basics, Inc. Compositions for improving mental performance
EP1503715A4 (en) 2002-05-03 2005-07-06 Martek Biosciences Corp HIGH QUALITY LIPIDS AND METHODS FOR THE PRODUCTION THEREOF BY ENZYMATIC RELEASE FROM BIOMASS
JP5503846B2 (ja) * 2005-01-24 2014-05-28 プロノヴァ・バイオファーマ・ノルゲ・アーエス アミロイドーシス関連疾患の治療のための医療品又は食料品の製造における、dhaを含有する脂肪酸組成物の使用
US8324276B2 (en) * 2005-01-24 2012-12-04 Pronova Biopharma Norge As Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction
WO2006116755A2 (en) * 2005-04-28 2006-11-02 Trustees Of Tufts College Synergitic effects of docosahexaenoic acid (dha) and carotenoid absorption of cognitive function
US10086009B2 (en) * 2005-05-23 2018-10-02 Massachusetts Institute Of Technologies Compositions containing pufa and/or uridine and methods of use thereof
BRPI0613358A8 (pt) * 2005-07-08 2017-12-26 Dsm Ip Assets Bv ácidos de gordura poli - insaturada para o tratamento da demência e condições relacionadas à pré-demência
WO2009002145A1 (en) * 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
WO2009006317A1 (en) 2007-06-29 2009-01-08 Martek Biosciences Corporation Production and purification of esters of polyunsaturated fatty acids
US20110177061A1 (en) * 2009-07-10 2011-07-21 Martek Biosciences Corporation Methods of treating and preventing neurological disorders using docosahexaenoic acid

Similar Documents

Publication Publication Date Title
JP2015143248A5 (enExample)
HRP20210686T1 (hr) Pripravci i postupci za liječenje moždanog udara kod subjekta na istodobnoj terapiji statinom
JP2015503590A5 (enExample)
JP2013521310A5 (enExample)
RU2020123679A (ru) Композиции и способы лечения и/или предотвращения сердечно-сосудистого заболевания
JP2019048843A5 (enExample)
JP2016511753A5 (enExample)
HK1204272A1 (en) Methods of treating pediatric metabolic syndrome
NZ734905A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
JP2015503593A5 (enExample)
EP4338805A3 (en) Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
NZ618734A (en) Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
PH12014501553A1 (en) Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
JP2008540394A5 (enExample)
NZ727980A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
RU2018111327A (ru) Способ ингибирования всасывания и/или повышения выведения липидов с использованием d-псикозы
JP2015520235A5 (enExample)
RU2018136872A (ru) Композиции, содержащие 15-oh эпк, и способы их применения
RU2013146517A (ru) Композиции и способы, пригодные для облегчения возрастных заболеваний
JP2016510326A5 (enExample)
JP2014512351A5 (enExample)
JP2016053065A5 (enExample)
WO2017077528A3 (en) Methods and pharmaceutical compositions for treatment of lung inflammation
JP2013507454A5 (enExample)
RU2019110980A (ru) Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением